- Home
- POWW vs FBRX Comparison
POWW vs FBRX Comparison
Compare POWW & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POWW
- FBRX
- Stock Information
- Founded
- POWW 1990
- FBRX N/A
- Country
- POWW United States
- FBRX United States
- Employees
- POWW N/A
- FBRX N/A
- Industry
- POWW Ordnance And Accessories
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- POWW Industrials
- FBRX Health Care
- Exchange
- POWW Nasdaq
- FBRX Nasdaq
- Market Cap
- POWW 167.5M
- FBRX 154.5M
- IPO Year
- POWW N/A
- FBRX N/A
- Fundamental
- Price
- POWW $1.45
- FBRX $14.60
- Analyst Decision
- POWW Buy
- FBRX Strong Buy
- Analyst Count
- POWW 2
- FBRX 3
- Target Price
- POWW $1.75
- FBRX $68.00
- AVG Volume (30 Days)
- POWW 726.1K
- FBRX 104.7K
- Earning Date
- POWW 08-08-2025
- FBRX 11-13-2025
- Dividend Yield
- POWW N/A
- FBRX N/A
- EPS Growth
- POWW N/A
- FBRX N/A
- EPS
- POWW N/A
- FBRX N/A
- Revenue
- POWW $44,004,480.00
- FBRX N/A
- Revenue This Year
- POWW $8.25
- FBRX N/A
- Revenue Next Year
- POWW $0.74
- FBRX N/A
- P/E Ratio
- POWW N/A
- FBRX N/A
- Revenue Growth
- POWW 62.90
- FBRX N/A
- 52 Week Low
- POWW $0.95
- FBRX $4.11
- 52 Week High
- POWW $2.14
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- POWW 51.09
- FBRX 56.63
- Support Level
- POWW $1.44
- FBRX $13.19
- Resistance Level
- POWW $1.51
- FBRX $15.49
- Average True Range (ATR)
- POWW 0.08
- FBRX 1.49
- MACD
- POWW -0.01
- FBRX 0.03
- Stochastic Oscillator
- POWW 26.09
- FBRX 53.74
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).